Umut Dişel

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Miao‐Zhen Qiu, Do‐Youn Oh, Ken Kato et al. · BMJ · 2024 · 245 citations · Full text

Medicine, Oncology, Pharmacology +17

Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial

Caicun Zhou, Dingzhi Huang, Yun Fan et al. · Journal of Thoracic Oncology · 2022 · 104 citations · Full text

Medicine, Oncology, Pharmacology +17

PRAME mRNA levels in cases with acute leukemia: Clinical importance and future prospects

Semra Paydaş, Kahraman Tanrıverdi, Sinan Yavuz et al. · American Journal of Hematology · 2005 · 71 citations · Full text

Medicine, Hematology, Oncology +17

Survivin and aven: two distinct antiapoptotic signals in acute leukemias

Semra Paydaş, Sinan Yavuz, Umut Dişel et al. · Annals of Oncology · 2003 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +12

Effect of colchicine on cyclosporine nephrotoxicity, reduction of TGF-beta overexpression, apoptosis, and oxidative damage: an experimental animal study

Umut Dişel, Saime Paydaş, Ayşe Doğan et al. · Transplantation Proceedings · 2004 · 48 citations

Medicine, Cell Biology, Pharmacology +9